Skip to content

Improving Quality of Life (QOL) measurement for melanoma patients and their families

Improving Quality of Life (QOL) measurement for melanoma patients and their families: Validity and reliability study of QOL insruments in an Australian sample

Status
Completed
Phases
Unknown
Study type
Observational
Source
ANZCTR
Registry ID
ACTRN12609000344291
Acronym
MEL-QOL Research Study
Enrollment
1060
Registered
2009-05-25
Start date
2009-06-01
Completion date
2010-12-31
Last updated
2021-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

A melanoma-specific QoL questionnaire is being developed in a cross-cultural setting using a four phase process developed by the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Group. This study has shown that melanoma patients have important QoL issues that have been incorporated into a new cross-culturally validated instrument.

Interventions

This is a questionnaire based study relying on participation at two levels. The first part of the study will involve conducting a set of focus group interviews with patients and their family members which will gather qualitative information about their experiences with melanoma diagnosis and treatment and how it has impacted on their quality of life (QOL). The focus group interviews would generally be 1-2 hour sessions and about 10 sessions in total would be held over a 3 month period (5 session

This is a questionnaire based study relying on participation at two levels. The first part of the study will involve conducting a set of focus group interviews with patients and their family members which will gather qualitative information about their experiences with melanoma diagnosis and treatment and how it has impacted on their quality of life (QOL). The focus group interviews would generally be 1-2 hour sessions and about 10 sessions in total would be held over a 3 month period (5 sessions for patients and 5 sessions for family members) depending on participant accrual. The second part of the study will involve participants completing a set of quality of life (QOL) questionnaires in addition to a composite set of new quality of life (QOL) items developed from the first part of the study. A set of 5 questionnaires would be distributed to each participant (patients and familiy members) and they would submit completed questionnaires on the day of the trial visit.

Sponsors

Melanoma and Skin Cancer Trials
Lead SponsorOther Collaborative groups

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

i) All melanoma patients attending clinics at Sydney Melanoma Unit (Melanoma Institute Australia), Sydney Cancer Centre (Royal Prince Alfred Hospital) and Westmead Cancer Care Centre (Westmead Hospital) ii) Participants must have sufficient English fluency

Exclusion criteria

i) Patients with current major psychiatric disturbance or mental illness ii) Participants with insufficient English fluency

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026